Top Midday Gainers

MT Newswires Live

Aug 19, 2025

Soligenix (SNGX) said Monday that the US Food and Drug Administration has granted orphan drug designation to dusquetide for the treatment of Behcet's disease, an inflammatory disorder of the blood vessels.

Shares surged 85% as intraday trading volume catapulted to more than 146.2 million from a daily average of about 8 million.

Propanc Biopharma (PPCB) shares soared 131% in heavy trading after midday on Monday following their debut on Nasdaq on Friday.

More than 63.3 million shares traded intraday.

Aspire Biopharma (ASBP) said Monday its investigational sublingual aspirin product demonstrated "higher and more rapid" mean plasma concentrations of acetylsalicylic acid, compared with standard chewed aspirin tablets.

Shares jumped 52%, with intraday trading volume at over 430.7 million from a daily average of about 15 million.

Price: 6.63, Change: +3.76, Percent Change: +130.84

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2560182419"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2560182419\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2560182419?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-19 01:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2560182419","market":"fut","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> Soligenix (SNGX) said Monday that the US Food and Drug Administration has granted orphan drug designation to dusquetide for the treatment of Behcet's disease, an inflammatory disorder of the blood vessels.</p><p>Shares surged 85% as intraday trading volume catapulted to more than 146.2 million from a daily average of about 8 million.</p><p><a href=\"https://laohu8.com/S/PPCB\">Propanc Biopharma</a> (PPCB) shares soared 131% in heavy trading after midday on Monday following their debut on Nasdaq on Friday.</p><p>More than 63.3 million shares traded intraday.</p><p><a href=\"https://laohu8.com/S/ASBP\">Aspire Biopharma</a> (ASBP) said Monday its investigational sublingual aspirin product demonstrated \"higher and more rapid\" mean plasma concentrations of acetylsalicylic acid, compared with standard chewed aspirin tablets.</p><p>Shares jumped 52%, with intraday trading volume at over 430.7 million from a daily average of about 15 million.</p><p>Price: 6.63, Change: +3.76, Percent Change: +130.84</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-19 01:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Soligenix (SNGX) said Monday that the US Food and Drug Administration has granted orphan drug designation to dusquetide for the treatment of Behcet's disease, an inflammatory disorder of the blood vessels.</p><p>Shares surged 85% as intraday trading volume catapulted to more than 146.2 million from a daily average of about 8 million.</p><p><a href=\"https://laohu8.com/S/PPCB\">Propanc Biopharma</a> (PPCB) shares soared 131% in heavy trading after midday on Monday following their debut on Nasdaq on Friday.</p><p>More than 63.3 million shares traded intraday.</p><p><a href=\"https://laohu8.com/S/ASBP\">Aspire Biopharma</a> (ASBP) said Monday its investigational sublingual aspirin product demonstrated \"higher and more rapid\" mean plasma concentrations of acetylsalicylic acid, compared with standard chewed aspirin tablets.</p><p>Shares jumped 52%, with intraday trading volume at over 430.7 million from a daily average of about 15 million.</p><p>Price: 6.63, Change: +3.76, Percent Change: +130.84</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2560182419","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2560182419","pubTimestamp":1755537882,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Soligenix  said Monday that the US Food and Drug Administration has granted orphan drug designation to dusquetide for the treatment of Behcet's disease, an inflammatory disorder of the blood vessels.Shares surged 85% as intraday trading volume catapulted to more than 146.2 million from a daily average of about 8 million.Propanc Biopharma  shares soared 131% in heavy trading after midday on Monday following their debut on Nasdaq on Friday.More than 63.3 million shares traded intraday.Aspire Biopharma  said Monday its investigational sublingual aspirin product demonstrated \"higher and more rapid\" mean plasma concentrations of acetylsalicylic acid, compared with standard chewed aspirin tablets.Shares jumped 52%, with intraday trading volume at over 430.7 million from a daily average of about 15 million.Price: 6.63, Change: +3.76, Percent Change: +130.84","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ASBP":"Aspire Biopharma Holdings Inc.","BK4139":"生物科技","PPCB":"Propanc Biopharma, Inc.","SNGX":"Soligenix, Inc."},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASBP":0.9,"PPCB":0.9,"SNGX":0.9},"content_text":"Soligenix (SNGX) said Monday that the US Food and Drug Administration has granted orphan drug designation to dusquetide for the treatment of Behcet's disease, an inflammatory disorder of the blood vessels.Shares surged 85% as intraday trading volume catapulted to more than 146.2 million from a daily average of about 8 million.Propanc Biopharma (PPCB) shares soared 131% in heavy trading after midday on Monday following their debut on Nasdaq on Friday.More than 63.3 million shares traded intraday.Aspire Biopharma (ASBP) said Monday its investigational sublingual aspirin product demonstrated \"higher and more rapid\" mean plasma concentrations of acetylsalicylic acid, compared with standard chewed aspirin tablets.Shares jumped 52%, with intraday trading volume at over 430.7 million from a daily average of about 15 million.Price: 6.63, Change: +3.76, Percent Change: +130.84","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}